Commentary on: Lipoprotein(a), remote ischemic conditioning, and stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis

Simple item page
dc.contributor.authorPutthanbut N.
dc.contributor.authorLee J.Y.
dc.contributor.authorBorlongan C.V.
dc.contributor.correspondencePutthanbut N.
dc.contributor.otherMahidol University
dc.date.accessioned2025-04-28T18:07:29Z
dc.date.available2025-04-28T18:07:29Z
dc.date.issued2025-01-01
dc.identifier.citationNeurotherapeutics (2025)
dc.identifier.doi10.1016/j.neurot.2025.e00590
dc.identifier.eissn18787479
dc.identifier.issn19337213
dc.identifier.scopus2-s2.0-105002909470
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/109812
dc.rights.holderSCOPUS
dc.subjectPharmacology, Toxicology and Pharmaceutics
dc.subjectMedicine
dc.titleCommentary on: Lipoprotein(a), remote ischemic conditioning, and stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105002909470&origin=inward
oaire.citation.titleNeurotherapeutics
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationUniversity of South Florida, Tampa

Files

Collections

Scopus 2025